RegenETP, Inc. (NJT.SG)

0,0358 0,0000 (0,00%) Al cierre: 08:07AM CEST

RegenETP, Inc.

1960 South 4250 West
Salt Lake City, UT 84104
United States
800 560 3983
https://www.polarityte.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 42

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Richard Hague	President, CEO & Director	441,24k	N/A	1960
Mr. Nikolai Sopko M.D., Ph.D.	Chief Scientific Officer and VP of R&D	N/A	N/A	N/A
Mr. Rich Haerle	Vice President of Investor Relations & Strategy	N/A	N/A	N/A
Mr. Mark E. Lehman J.D.	Chief Legal Officer	N/A	N/A	N/A
Angela Ziegler	Vice President of Marketing & Public Relations	N/A	N/A	N/A
Mr. Alain Adam	Vice President of Sales	N/A	N/A	N/A
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.	Senior VP of Corporate Development & President of Contract Services	N/A	N/A	1962
Mr. Ryan Mathis M.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Kolby Day Esq.	Senior Vice President of Manufacturing Operations	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Gobierno corporativo

El ISS Governance QualityScore de RegenETP, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.